TABLE 2.
No methylation mosaicism |
With methylation mosaicism |
p | No size mosaicism |
With size mosaicism |
p | |||||
---|---|---|---|---|---|---|---|---|---|---|
N | Mean (± SD) | N | Mean (± SD) | N | Mean (± SD) | N | Mean (± SD) | |||
Severity of IDa | 341 | 3.82 (±0.74) | 87 | 3.41 (±0.87) | <0.001 | 344 | 3.78 (±0.76) | 84 | 3.52 (±0.84) | 0.140 |
VABSb | 130 | 55.19 (±15.60) | 43 | 63.84 (±17.76) | 0.002 | 139 | 55.88 (±16.21) | 34 | 63.29 (±16.79) | 0.481 |
ABCFXc | 330 | 100.33 (±28.19) | 84 | 96.43 (±28.98) | 0.337 | 334 | 100.13 (±28.63) | 80 | 97.06 (±27.22) | 0.444 |
SRSFXd | 280 | 68.77 (±20.70) | 72 | 60.85 (±19.01) | 0.020 | 279 | 68.49 (±20.44) | 73 | 62.04 (±20.49) | 0.120 |
Severity of ID was categorized based on clinician report as 1 = no ID, 2 = borderline ID, 3 = mild ID, 4 = moderate ID, 5 = severe ID, and 6 = profound ID.
VABS measure adaptive skills, with higher scores indicating higher adaptive skills.
ABCFX measures 6 problem behaviors: irritability, social withdrawal, stereotypic behavior, hyperactivity/noncompliance, inappropriate speech, and social avoidance, with higher scores indicating more aberrant behavior.
SRSFX measures social ability, with higher scores indicating more severe social impairment.